document
May 6, 2014 — 00:00
PDF File
- FR
- EN
4301
-
-
documentMay 6, 2014 — 00:00
PDF File
-
documentMay 6, 2014 — 00:00
SCOR Global Life Embedded Value increases 29% to EUR 4.5 billion in 2013 (EUR 24.10 per share), continuing to provide the Group with significant earnings and strong capital repatriation
-
documentMay 6, 2014 — 00:00
PDF File
-
documentMay 6, 2014 — 00:00
PDF File
-
documentMay 6, 2014 — 00:00
All the proposed resolutions were adopted by SCOR’s shareholders by a very large majority, including payment of a dividend of EUR 1.30 per share for the 2013 financial year.
-
Press ReleasesSCOR Global P&C’s April renewals.
-
documentApril 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
-
documentApril 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets.
-
documentApril 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
-
documentApril 28, 2014 — 00:00
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
-
documentApril 28, 2014 — 00:00
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
